Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
91151 trials found · Page 130 of 4558
-
Giant suction tube vs. stent snare: which saves more brain?
Disease control Not yet recruitingThis is a multicenter, open-label, blinded-endpoint, randomized controlled trial comparing super large bore catheter aspiration versus stent retriever thrombectomy as the first-line technique for anterior circulation large vessel occlusion in acute ischemic stroke. Eligible patie…
Phase: NA • Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
Could a 50-year-old drug beat dengue? new trial aims to find out.
Disease control Not yet recruitingThe goal of this study is to evaluate the efficacy and safety of emetine administered orally for symptomatic patients aged 18-65 years infected with the dengue virus. The main questions it aims to answer are: 1. Does emetine reduce 28-day mortality or progression to severe dengu…
Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Brain surgery breakthrough tested for Parkinson's treatment
Disease control Not yet recruitingThis study is being done to test a new way of delivering AB-1005 into the brain. The goal is to make the procedure easier and quicker to perform, while providing similar amounts of drug to the part of the brain that needs treatment. Technical (Stage 1) To test if the new deliver…
Phase: PHASE2 • Sponsor: AskBio Inc • Aim: Disease control
Last updated Apr 20, 2026 16:15 UTC
-
New mRNA vaccine aims to prevent shingles in older adults
⭐️ VACCINE ⭐️ Not yet recruitingThe study will evaluate the safety, tolerability, and immunogenicity (your immune system's reaction) of 3 dose levels of the study vaccine called Herpes Zoster IN001 mRNA Vaccine (IN001) in healthy participants who are between 50 and 79 years of age.
Phase: PHASE2 • Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 04, 2026 16:21 UTC
-
Magic mushroom therapy takes on alcoholism: new trial tests psilocybin doses
Disease control Not yet recruitingThis study aims to determine the safety and preliminary efficacy of psilocybin-assisted psychotherapy in improving alcohol-related outcomes among adults with severe alcohol use disorder in a a double-blind, dose-comparison concurrent control, randomized trial. Participants will u…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New study aims to save organs in stomach cancer patients
Disease control Not yet recruitingThis study will test a new personalized treatment approach for patients with stomach or esophageal cancer. It will take place in two stages and aims to find the best combination of chemotherapy, immunotherapy, and targeted drugs based on each patient's tumor biomarkers. Upon enr…
Phase: PHASE2 • Sponsor: American Association for Cancer Research • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
Engineered immune cells take on hard-to-treat cancers in early trial
Disease control Not yet recruitingOnly enrolling in Canada. The purpose of this study is to identify the highest dose of GCAR1, a chimeric antigen receptor (CAR-T) cell therapy, that can be tolerated without causing very severe side effects, and to see what effects GCAR1 has on selected cancers
Phase: PHASE1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
New hope for lung cancer patients with brain tumors: drug combo trial launches
Disease control Not yet recruitingThis is a prospective, open-label, multi-center, single-arm clinical trial
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated May 07, 2026 18:13 UTC
-
Weight-Loss drug tirzepatide may cut AFib recurrence after ablation in obese patients
Disease control Not yet recruitingThe goal of this clinical trial is to determine whether tirzepatide can reduce atrial fibrillation (AF) burden after catheter ablation in overweight or obese patients with persistent AF. It will also evaluate the effects of tirzepatide on body weight, metabolic risk factors, and …
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated May 07, 2026 18:12 UTC
-
New drug combo aims to beat stubborn bone infections
Disease control Not yet recruitingA Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Efficacy and Safety of Bisphosphonates Combined with Vancomycin in the Treatment of Refractory Osteomyelitis
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 07, 2026 18:13 UTC
-
Bone-Shifting surgery could heal diabetic wounds and prevent amputations
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety and clinical performance of transverse tibial bone transport in patients with chronic ischemic and diabetic lower extremity ulcers. This study will assess wound healing outcomes and limb preservation in a population with limited…
Phase: NA • Sponsor: Biodynamik, Inc • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
New shot could bring relief to millions with severe eczema
Disease control Not yet recruitingRationale (What is the reason for this study?) Atopic dermatitis (AD) is a condition that makes the skin dry and itchy and is the most common skin condition that causes redness and irritation. The exact cause of AD is unclear but genetic and environmental factors are believed to…
Phase: PHASE3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Disease control
Last updated May 07, 2026 18:09 UTC
-
New personalized safety plans aim to curb veteran suicide after hospital discharge
Symptom relief Not yet recruitingVeterans psychiatrically hospitalized face significantly elevated suicide risk, particularly in the three months post-discharge. While Safety Planning is a required component of discharge planning, many safety plans lack personalization thereby reducing their effectiveness. The p…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Apr 26, 2026 19:36 UTC
-
New hope for lymphoma patients: Chemo-Free cocktail aims to control aggressive cancer
Disease control Not yet recruitingThis is a single-center, phase 2, open-label clinical trial of a novel combination of polatuzumab vedotin, glofitamab, and tafasitamab (TPG) as first-line treatment of patients with diffuse large B cell lymphoma (DLBCL) or high-grade B cell lymphoma (HGBL).
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
Promising drug cocktail aims to wipe out esophageal tumors before surgery
Disease control Not yet recruitingIn the management of locally advanced esophageal squamous cell carcinoma, the outcomes associated with surgical resection, whether conducted alone or supplemented with postoperative adjuvant radiotherapy and chemotherapy, have been suboptimal. Immune checkpoint inhibitors (ICIs) …
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New hope for advanced lung cancer: heat therapy plus drugs tested after first treatment fails
Disease control Recruiting nowThe purpose of this clinical trial is to evaluate progression-free survival (PFS) of microwave ablation in combination with tislelizumab and docetaxel in patients with advanced non-small cell lung cancer (NSCLC) who have progressed following first-line immunotherapy combined with…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
Every second counts: can Pocket-Sized defibrillators double cardiac arrest survival?
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to learn the feasibility of equipping the volunteer community responders (VCR) with the mobile external automated defibrillators (mAEDs) for the management of adults experiencing out-of-hospital cardiac arrest (OHCA) patients. It will also provi…
Phase: NA • Sponsor: Singapore General Hospital • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC
-
New scan spots hidden heart clots in rare disease
Diagnosis Recruiting nowThe primary goal of this pilot study is to determine whether \[64Cu\]FBP8, a novel fibrin-binding positron emission tomography (PET) probe, can identify intracardiac thrombi when paired with simultaneous hybrid cardiac PET/MRI in twenty (20) individuals with transthyretin or ligh…
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated May 04, 2026 16:22 UTC
-
Steroid shield: new hope to prevent HIV treatment complications
Prevention Not yet recruitingThis study was a multicenter, open-label, randomized controlled clinical trial designed to evaluate the efficacy and safety of glucocorticoids in preventing paradoxical immune reconstitution inflammatory syndrome (IRIS) in patients with AIDS complicated by opportunistic infection…
Phase: NA • Sponsor: Shanghai Public Health Clinical Center • Aim: Prevention
Last updated May 06, 2026 16:15 UTC
-
Promising drug aims to stop relapses in kids with rare nerve disease
Disease control Recruiting nowThis study will primarily evaluate the pharmacokinetics of satralizumab in pediatric patients aged 2-11 years with anti-aquaporin-4 (AQP4) antibody seropositive neuromyelitis optica spectrum disorder (NMOSD). Efficacy, safety, tolerability, and pharmacodynamics will be evaluated …
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 07, 2026 18:11 UTC